The Montreal Heart Institute stands out at the prestigious European Society of Cardiology congress
Home > Press room > The Montreal Heart Institute stands out at the prestigious European Society of Cardiology congress
Copied link!
Share
August 31, 2020
─
During the prestigious virtual congress of the European Society of Cardiology (ESC), researchers from the Montreal Heart Institute presented recent data regarding the impact of colchicine on cardiovascular disease.
These three new analyses from the COLCOT (COLchicine Cardiovascular Outcomes Trial) clinical trial confirm the benefits of colchicine, an inexpensive and already available drug, to prevent cardiovascular events in patients who survived a heart attack, also known as myocardial infarction.
find out more by visiting the Institute’s websitePress Room
December 6, 2023The Right Honourable Brian Mulroney and Mrs. Mila Mulroney donate $1.5 million to support the foundations of two hospitals and a research institute
October 31, 2023Céline Auger, Dominique Morency-Laflamme, and Isabelle Gauthier named recipients of the 2023 Dr. Denis Roy Awards for Excellence in Cardiovascular Care
September 8, 202323rd edition of the Grand Bal des Vins-Cœurs: $1,380,000 raised for the Montreal Heart Institute Foundation